Brian G Feagan

52PUBLICATIONS
120CO-AUTHORS
Predictive and prognostic markersCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jan 22, 2026
Association between endo-histological outcomes and colonic mucosal transcriptomic profiles in patients with ulcerative colitis receiving filgotinib.

Fernando Magro, Gerhard Rogler, Brian G Feagan

|Oct 16, 2025
Crohn Disease Strictures: Multimodality Imaging to Identify Imaging Biomarkers.

Safa Hoodeshenas, Jonathan R Dillman, Stuart A Taylor

|Mar 21, 2025
Pharmacokinetic Comparability and Safety Between Original and Citrate-Free Mirikizumab Formulations for Subcutaneous Injections: Results from Three Clinical Trials.

Yuki Otani, Brian G Feagan, Geert R D'Haens

|Feb 17, 2025
Therapeutic Drug Monitoring for Dose Optimization of Infliximab in Patients With Inflammatory Bowel Disease: An Analysis of Canadian Real-World Data.

David C Sealey, Kai Fai Ho, Z Christina Zhou

|Feb 03, 2025
Certolizumab Pegol Treatment in Patients With Crohn's Disease: Final Safety Data From the SECURE Registry.

Gary R Lichtenstein, Scott D Lee, Brian G Feagan

|Aug 06, 2024
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease.

Florian Rieder, Christopher Ma, Jurij Hanzel

Pageof 9

Frequent Collaborators

20 joint publications

Vipul Jairath

15 joint publications

Christopher Ma

15 joint publications

William Sandborn

9 joint publications

Rish K Pai